Triamcinolone Acetonide

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Triamcinolone Acetonide
Generic name: TRIAMCINOLONE ACETONIDE
Manufacturer: Preferred Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: a1633e66-2ce8-42e4-8046-ac10dadfa34b
SPL ID: 75732c9f-6add-4ca2-88a3-da247d4b8d93
Version: 3
Effective date: 2025-10-01
Source export date: 2026-09-28
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/c7ca0b7091cdaeab3f27713a6eef00adcf8fe722383633ddce61531b4c840544/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:27:31

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	040771	derived:openfda.application_number
application number		ANDA040771	openfda.application_number
brand name		Triamcinolone Acetonide	openfda.brand_name
generic name		TRIAMCINOLONE ACETONIDE	openfda.generic_name
manufacturer name		Preferred Pharmaceuticals, Inc.	openfda.manufacturer_name
ndc	package	68788-8386-5	openfda.package_ndc
ndc	product	68788-8386	openfda.product_ndc
ndc11	package	68788838605	derived:openfda.package_ndc
spl id		75732c9f-6add-4ca2-88a3-da247d4b8d93	id
spl set id		a1633e66-2ce8-42e4-8046-ac10dadfa34b	set_id
unii		F446C597KA	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS The following local adverse reactions may occur with corticosteroid-containing dental pastes: burning, itching, irritation, dryness, blistering or peeling not present prior to therapy, perioral dermatitis, allergic contact dermatitis, maceration of the oral mucosa, secondary infection, and atrophy of the oral mucosa. Also, see PRECAUTIONS for potential effects of systemic absorption. To report SUSPECTED ADVERSE REACTIONS, contact Rising Pharma Holdings, Inc. at 1-844-874-7464 or FDA at 1-800-FDA-1008 or www.fda.gov/medwatch.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.